CalciMedica
CALC
29 hedge funds and large institutions have $15.1M invested in CalciMedica in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
21% more funds holding
Funds holding: 24 → 29 (+5)
11% more capital invested
Capital invested by funds: $13.6M → $15.1M (+$1.54M)
0.63% more ownership
Funds ownership: 5.7% → 6.33% (+0.63%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.64M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.3M |
| 3 |
DM
Deerfield Management
New York
|
+$1.05M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$298K |
| 5 |
Renaissance Technologies
New York
|
+$151K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$682K |
| 2 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$67K |
| 3 |
First Manhattan
New York
|
-$58.6K |
| 4 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$37K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
CALC Hedge Fund Activity: Q4 2024 in Review
29 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2024, worth a combined $15.1M — up 11% from $13.6M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CALC positions and 5 closed out — a net gain of 5 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $1.64M. The largest seller was BML Capital Management, exiting entirely with an estimated $682K sold.
- 29 institutional investors held CalciMedica (CALC) as of Q4 2024, up from 24 in Q3 2024.
- Funds reported $15.1M of CalciMedica stock for Q4 2024, up 11% quarter-over-quarter.
- 10 funds opened new CalciMedica positions in Q4 2024 and 5 closed out, a net change of +5 holders.
- The largest CalciMedica buyer in Q4 2024 was Stonepine Capital Management, an estimated $1.64M added.
- The largest CalciMedica seller in Q4 2024 was BML Capital Management, an estimated $682K sold.
Based on aggregated 13F filings for Q4 2024.